The board approved the reappointment of Mukundan based on the company’s Nomination and Remuneration Committee’s recommendation
Tata Chemicals’ board has re-appointed R Mukundan as MD & CEO for a further term of five years, with effect from November 26, 2023 subject to shareholders’ approvals.
The company’s board approved the re-appointment of Mukundan based on the company’s Nomination and Remuneration Committee’s recommendation. The company will seek shareholders’ approval at its forthcoming annual general meeting, Tata Chemicals said in a stock exchange update.
His present tenure as MD & CEO will end on November 25, 2023.
Mukundan joined Tata Administrative Service in 1990, after completion of MBA from FMS, Delhi University. During his more than three-decade with the Tata Group, he has held various responsibilities across the chemical, automotive and hospitality sectors of the Tata Group.
Register Now to Attend Chem Connect 2025 on August 21th 2025, Novotel Mumbai International Airport
Subscribe To Our Newsletter & Stay Updated